Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trials in India.

Rituparna Maiti1, Raghavendra M

  • 1Department of Pharmacology, Prathima Institute of Medical Sciences, Nagunur Road, Karimnagar-505417, Andhra Pradesh, India. rituparnamaiti@rediffmail.com

Pharmacological Research
|March 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychiatric comorbidities and treatment patterns in epilepsy: A retrospective review from a tertiary neuropsychiatric clinic.

Indian journal of psychiatry·2026
Same author

Mitochondrial dysfunction in schizophrenia and its modulation by atypical antipsychotic drugs: A randomized controlled trial.

Journal of psychopharmacology (Oxford, England)·2026
Same author

Lumateperone as an alternative to clozapine in treatment-resistant schizophrenia: Insights from a quantitative systems pharmacology model.

The Journal of pharmacology and experimental therapeutics·2026
Same author

Null result: Inconvenient, underreported, and indispensable!

Indian journal of pharmacology·2026
Same author

Precision dosing of clozapine: A physiologically based pharmacokinetic/pharmacodynamic model integrating genetic polymorphisms and clinical outcomes.

Journal of psychopharmacology (Oxford, England)·2026
Same author

Augmentation of clozapine with dextromethorphan in treatment-resistant schizophrenia: A randomized, group sequential adaptive design, controlled clinical trial.

Asian journal of psychiatry·2026
Same journal

Ketohexokinase: A central mediator of fructose-associated pathogenesis and promising therapeutic target.

Pharmacological research·2026
Same journal

GLP-1-based combination strategies for weight loss: Multi-target agents and combination therapies.

Pharmacological research·2026
Same journal

Cajaninstilbene acid in macrophage immunometabolism and angiogenesis: Mechanisms and therapeutic potential.

Pharmacological research·2026
Same journal

From Mechanisms to Therapy: Targeting the Gut-Brain Axis in Chronic Gastrointestinal Pain.

Pharmacological research·2026
Same journal

Natural product emodin-based nanodrug delivery systems: Advancements and applications.

Pharmacological research·2026
Same journal

Targeting androgen receptor transcriptionally represses VCP and enhances the efficacy of oncolytic-immunotherapy in hepatocellular carcinoma.

Pharmacological research·2026
See all related articles

Pharmaceutical companies are outsourcing drug development globally. India is a top choice for contract research due to its population and skills, but requires further development to fully succeed in clinical trials.

Area of Science:

  • Pharmaceutical Research
  • Drug Development Outsourcing
  • Clinical Trials

Background:

  • Outsourcing drug development is common in the pharmaceutical industry due to cost and uncertainty.
  • India is emerging as a preferred global destination for contract pharmaceutical research and development.
  • Factors contributing to India's appeal include a large treatment-naïve population, skilled workforce, and evolving regulatory landscape.

Purpose of the Study:

  • To analyze India's potential as a hub for pharmaceutical outsourcing and clinical trials.
  • To identify key factors driving the preference for India in contract research and development.
  • To assess the challenges and opportunities for India in attracting multinational pharmaceutical companies.

Main Methods:

  • Literature review of pharmaceutical outsourcing trends.

Related Experiment Videos

  • Analysis of India's demographic, economic, and regulatory factors.
  • Comparative assessment of India's capabilities in contract research and development.

    • Main Results:

    • India possesses significant advantages for outsourcing, including a large, treatment-naïve population and a skilled scientific workforce.
    • Regulatory authorities in India are adapting laws and regulations to support pharmaceutical research.
    • Despite its potential, India needs to address certain prerequisites to fully capitalize on its position.

    Conclusions:

    • India is well-positioned to become a leading location for global drug development and clinical trials.
    • Continued development and addressing existing challenges are crucial for India's long-term success in pharmaceutical outsourcing.
    • The country's optimistic outlook and strategic advantages make it an attractive destination for multinational pharmaceutical investment.